CGEM: Cullinan Therapeutics, Inc. Stock

by  •  • Comments Off on CGEM: Cullinan Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 509.30
Enterprise Value ($M) -58.11
Book Value ($M) 551.84
Book Value / Share 9.35
Price / Book 0.92
NCAV ($M) 539.56
NCAV / Share 9.14
Price / NCAV 0.94

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.40
Return on Equity (ROE) -0.42

Liquidity (mrq)
Quick Ratio 20.75
Current Ratio 20.75

Balance Sheet (mrq) ($M)
Current Assets 567.40
Assets 579.68
Liabilities 27.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -196.92
Net Income -167.38

Cash Flow Statement (mra) ($M)
Cash From Operations -145.30
Cash from Investing -136.31
Cash from Financing 266.19

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Biotechnology Value Fund L P 9.99 31.94
11-14 13G/A Blue Owl Capital Holdings LP 3.45 -41.20
11-12 13G/A Vanguard Group Inc 5.17 0.00
11-08 13G BlackRock, Inc. 7.50 0.00
10-31 13G/A Franklin Resources Inc 3.80 -33.22

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 94,815 382,649 24.78
2025-05-29 135,615 551,596 24.59
2025-05-28 18,408 167,366 11.00
2025-05-27 25,006 198,824 12.58

(click for more detail)

Similar Companies
CABA – Cabaletta Bio, Inc. CCCC – C4 Therapeutics, Inc.
CGC – Canopy Growth Corporation CGON – CG Oncology, Inc.
COGT – Cogent Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io